Reaxys Announces Winners of the 2012 Reaxys PhD Prize

Informations

• Publié par: Elsevier
• Nombre de lectures: 57
• Langue: English

Extrait

Reaxys Announces Winners of the 2012

Reaxys PhD Prize

PR Newswire

NEUCHÂTEL, Switzerland, June 19, 2012

NEUCHÂTEL,

Switzerland

,

June 19, 2012

/PRNewswire/ --

The Reaxys PhD Prize awards original and innovative research in organic,

organometallic and inorganic chemistry

Reaxys announces the winners of the Reaxys PhD Prize. Awarding innovative

and original research in organic, organometallic and inorganic chemistry, the

Reaxys PhD Prize celebrates the top research being performed by leading

young chemists across the globe.

The 2012 Reaxys PhD Prize Winners are:

Gregory Hamilton

at University of California, Berkeley

USA

Debashis Mandal

at

Nagoya

University,

Japan

Craig Stivala

, University of California, Santa Barbara,

USA

The winners have been selected from 45 finalists (see http://prize.reaxys.com/

for details of all the finalists) by the Chairs of the Review Board: Professors

Tony Barrett (Imperial College, UK), Barry Trost (Stanford,

USA

) and Henry

Wong (Chinese University

Hong Kong, China

).

Professor Wong said, "The prize goes from strength to strength. The three

winners feel very proud to have been selected from such a strong and diverse

field of applicants. I am personally very pleased to see such a diverse set of

chemistries represented. This year there were a significant number of inorganic

and organometallic submissions in addition to the usual strong organic

submissions. I am sure that all of these young chemists have extremely bright

futures ahead of them."

Launched in

January 2010

the Reaxys PhD Prize has received over 900

submissions from well over 400 of the world's top chemistry institutions. This

year a record 350 submissions were received from 39 countries. Submissions

consisted of a representative peer-reviewed piece of published research, PhD

supervisor's recommendation letter and a CV. Entries were closely scrutinized

by a review board of over 80 international chemists from academia and

industry. The reviewers judged the entries for originality, innovation,

importance to the field, applicability, rigor of approach and publication quality.

The three winners and 42 other finalists have each been invited to attend the

Reaxys PhD Prize Symposium at the 244th American Chemical Society Meeting

in

Philadelphia

, on

Sunday August 19 2012

. The winners are invited to give an

oral presentation of their research, and the finalists will participate in a special

poster session and reception. The symposium will also feature presentations

from Professors Martin Jansen (Max-Planck,

Stuttgart, Germany

) and Barry

Trost (Stanford,

USA

)

To learn more about the Reaxys PhD Prize please visit http://prize.reaxys.com.

To learn more about Reaxys® please visit http://www.reaxys.com. Reaxys®

and the Reaxys® trademark are owned and protected by Reed Elsevier

Properties SA and used under license.

# # #

About Reaxys®

Reaxys® is a workflow solution for research chemists. Offering a wealth of

experimentally validated information, Reaxys® combines reaction and

substance data in organic, organometallic, inorganic and physical chemistry

with synthesis planning. Researchers can get the information they need in a

single overview, from source publications carefully selected for their

importance and relevance to research chemists. Elsevier continues to engage

with the chemistry community to ensure that Reaxys® continues to reflect how

chemists think and work. For more information please

visit https://www.reaxys.com/info/.

Reaxys and the Reaxys trademark are owned and protected by Reed Elsevier

Properties SA and used under license.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical

information products and services. The company works in partnership with the

global science and health communities to publish more than 2,000 journals,

including

The Lancet

and

Cell

, and close to 20,000 book titles, including major

reference works from Mosby and Saunders. Elsevier's online solutions include

ScienceDirect, Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which

enhance the productivity of science and health professionals, and the SciVal

suite and MEDai's Pinpoint Review, which help research and health care

institutions deliver better outcomes more cost-effectively.

A global business headquartered in

Amsterdam

, Elsevier employs 7,000 people

worldwide. The company is part of Reed Elsevier Group PLC, a world-leading

publisher and information provider, which is jointly owned by Reed Elsevier PLC

and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL

(London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Reed Elsevier Properties SA

Reed Elsevier Properties SA is a centre of excellence within Reed Elsevier for

the management, development and protection of intellectual property. Reed

Elsevier Properties SA owns the PharmaPendium and Reaxys databases.

Trademarks including Reaxys®, PharmaPendium®, Targetinsights™, The

Lancet® and World Travel Market® are owned and protected by Reed Elsevier

Properties SA and used under licence.

Media contact

Tom Reller

Vice President, Global Corporate Relations, Elsevier

[phone]

[e-mail]